menu
    • menu

    Company profile for Intercept Pharmaceuticals

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-...
    We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Intercept PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10 Hudson Yards, 37th Floor, New York, NY 10001
    Telephone
    Telephone
    +646-747-1000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.interceptpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/intercept-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/InterceptPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intercept's Next-Gen FXR Agonist Fails Phase 2
    Intercept's Next-Gen FXR Agonist Fails Phase 2

    05 May 2026

    // ENDPOINTS

    https://endpoints.news/intercepts-next-gen-fxr-agonist-fails-phase-2-in-latest-setback-for-italian-owned-pharma/

    ENDPOINTS
    05 May 2026
    Share Share
    Intercept Fires 146 After Pulling Liver Disease Drug
    Intercept Fires 146 After Pulling Liver Disease Drug

    18 Dec 2025

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    18 Dec 2025
    Share Share
    Intercept, On Heels Of Ocaliva Pull, Warns Of 146 Layoffs
    Intercept, On Heels Of Ocaliva Pull, Warns Of 146 Layoffs

    17 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/intercept-heels-ocaliva-withdrawal-restructures-146-layoffs

    FIERCE PHARMA
    17 Dec 2025
    Share Share
    Intercept Pulls Liver Disease Drug After Regulator's Request
    Intercept Pulls Liver Disease Drug After Regulator's Request

    12 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/intercept-pharma-pulls-liver-disease-drug-us-after-regulators-request-2025-09-11/

    REUTERS
    12 Sep 2025
    Share Share
    Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold
    Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148535/23024/en/Intercept-Announces-Voluntary-Withdrawal-of-OCALIVA-for-Primary-Biliary-Cholangitis-PBC-from-the-US-Market-US-Clinical-Trials-Involving-Obeticholic-Acid-Placed-on-Clinical-Hold.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Cristcot Appoints Richard Kim as Chief Commercial Officer
    Cristcot Appoints Richard Kim as Chief Commercial Officer

    10 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cristcot-appoints-richard-kim-as-chief-commercial-officer-302476944.html

    PR NEWSWIRE
    10 Jun 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search